We are live on ! Find out more
AC

Apogem Capital Portfolio holdings

AUM $303K
1-Year Est. Return 46.01%
This Fund
S&P 500
This Quarter Est. Return
-1.39%
1 Year Est. Return
-46.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$157M
AUM Growth
+$672K
Cap. Flow
+$4.13M
Cap. Flow %
2.63%
Top 10 Hldgs %
22.36%
Holding
229
New
40
Increased
57
Reduced
64
Closed
43

Top Buys

Rank Stock Value
1
ZETA icon
Zeta Global
ZETA
+$5M
2
ACCD
Accolade Inc
ACCD
+$2.18M
3
GPRE icon
Green Plains
GPRE
+$1.49M
4
TTSH
Tile Shop Holdings
TTSH
+$1.35M
5
BP icon
BP
BP
+$1.25M

Sector Composition

Rank Sector Weight
1 Technology 26.88%
2 Consumer Discretionary 14.37%
3 Industrials 14.08%
4 Financials 12.8%
5 Healthcare 9.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATIP
226
DELISTED
ATI Physical Therapy, Inc.
ATIP
-264
Closed -$126K

Similar funds

Apogem Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Apogem Capital held 229 positions worth $157M, up 0.43% from $156M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Apogem Capital's Q3 2021 filing shows 40 new, 57 increased, 64 reduced and 43 closed positions. Its largest new stake was Zeta Global: 784,215 shares worth $4.59M. The largest sale was At Home Group Inc., an estimated $4.65M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Apogem Capital's largest Q3 2021 buy was Zeta Global: 784,215 shares worth $4.59M.
  • Apogem Capital added most to Green Plains in Q3 2021, an estimated $1.49M increase.
  • Apogem Capital's biggest Q3 2021 reduction was Aon, cutting an estimated $1.81M.
  • Apogem Capital fully exited At Home Group Inc. in Q3 2021, selling an estimated $4.65M.
  • Apogem Capital's ten largest holdings make up 22% of its $157M portfolio in Q3 2021.
  • Apogem Capital opened 40 new positions and closed 43 in Q3 2021.
  • Apogem Capital's portfolio value rose 0.43% quarter-over-quarter to $157M.

Based on Apogem Capital's 13F filing for Q3 2021, filed 15 Nov 2021.